Drug information for SODIUM THIOSULFATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 250MG/ML Discontinued   SODIUM THIOSULFATE sodium thiosulfate US ARMY 20166
SOLUTION; INTRAVENOUS 12.5GM/50ML (250MG/ML) Prescription  (Reference Drug) SODIUM THIOSULFATE sodium thiosulfate HOPE PHARMS 203923
2012-03-15 Review
2012-03-15 Summary Review
2012-02-21 Letter
2012-02-17 Label

Drug Adverse Effects information for SODIUM THIOSULFATE

Role code Indications Reaction # Reports
SS CALCIPHYLAXIS FLUID OVERLOAD 1
SS CALCIPHYLAXIS FURUNCLE 1
SS CALCIPHYLAXIS GAIT DISTURBANCE 1
SS CALCIPHYLAXIS HYPOTENSION 1
SS CALCIPHYLAXIS MOBILITY DECREASED 1
SS CALCIPHYLAXIS OEDEMA PERIPHERAL 1
SS OESOPHAGEAL SQUAMOUS CELL CARCINOMA LEUKOPENIA 1
SS OESOPHAGEAL SQUAMOUS CELL CARCINOMA STOMATITIS 1
SS PERITONEAL DIALYSIS FLUID OVERLOAD 1
SS PERITONEAL DIALYSIS FURUNCLE 1
SS PERITONEAL DIALYSIS GAIT DISTURBANCE 1
SS PERITONEAL DIALYSIS HYPOTENSION 1
SS PERITONEAL DIALYSIS MOBILITY DECREASED 1
SS PERITONEAL DIALYSIS OEDEMA PERIPHERAL 1
SS TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED HAEMOGLOBIN DECREASED 2
SS TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED LEUKOPENIA 3
SS TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED MOUTH HAEMORRHAGE 2
SS TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED STOMATITIS 3
SS TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED VASCULAR PSEUDOANEURYSM 2
C ANGIOGRAM ARTHRALGIA 5
C ANGIOGRAM DYSSTASIA 5
C ANGIOGRAM GAIT DISTURBANCE 5
C ANGIOGRAM JOINT CONTRACTURE 5
C ANGIOGRAM JOINT RANGE OF MOTION DECREASED 5
C ANGIOGRAM LICHENIFICATION 5
C ANGIOGRAM NEPHROGENIC SYSTEMIC FIBROSIS 5
C ANGIOGRAM OCULAR ICTERUS 5
C ANGIOGRAM OEDEMA PERIPHERAL 5
C ANGIOGRAM PAIN 5
C ANGIOGRAM PULMONARY FIBROSIS 5
C ANGIOGRAM SKIN HYPERPIGMENTATION 5
C ANGIOGRAM SKIN INDURATION 5
C ANGIOGRAM SKIN TIGHTNESS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING ARTHRALGIA 5
C NUCLEAR MAGNETIC RESONANCE IMAGING DYSSTASIA 5
C NUCLEAR MAGNETIC RESONANCE IMAGING GAIT DISTURBANCE 5
C NUCLEAR MAGNETIC RESONANCE IMAGING JOINT CONTRACTURE 5
C NUCLEAR MAGNETIC RESONANCE IMAGING JOINT RANGE OF MOTION DECREASED 5
C NUCLEAR MAGNETIC RESONANCE IMAGING LICHENIFICATION 5
C NUCLEAR MAGNETIC RESONANCE IMAGING NEPHROGENIC SYSTEMIC FIBROSIS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING OCULAR ICTERUS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING OEDEMA PERIPHERAL 5
C NUCLEAR MAGNETIC RESONANCE IMAGING PAIN 5
C NUCLEAR MAGNETIC RESONANCE IMAGING PULMONARY FIBROSIS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN HYPERPIGMENTATION 5
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN INDURATION 5
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN TIGHTNESS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ARTHRALGIA 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN DYSSTASIA 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN GAIT DISTURBANCE 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN JOINT CONTRACTURE 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN JOINT RANGE OF MOTION DECREASED 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN LICHENIFICATION 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN NEPHROGENIC SYSTEMIC FIBROSIS 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN OCULAR ICTERUS 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN OEDEMA PERIPHERAL 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN PAIN 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN PULMONARY FIBROSIS 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN SKIN HYPERPIGMENTATION 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN SKIN INDURATION 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN SKIN TIGHTNESS 1
Ads by Google